These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 4906103)
1. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis. Meissner G Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103 [No Abstract] [Full Text] [Related]
2. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis. Kraan JK; Mulder RJ; van Dijk B Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104 [No Abstract] [Full Text] [Related]
3. Five years of clinical experience with rifampicin. Gyselen A; Cosemans J; Lacquet LM; Vandenbergh E; Verbist L Acta Tuberc Pneumol Belg; 1971; 62(4):289-307. PubMed ID: 4948635 [No Abstract] [Full Text] [Related]
4. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)]. Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477 [TBL] [Abstract][Full Text] [Related]
5. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy]. Freerksen E Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222 [No Abstract] [Full Text] [Related]
6. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]
7. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients]. Ganiev KG; Esanbaev DE; Kirina SB Probl Tuberk; 1983 May; (5):42-6. PubMed ID: 6866983 [No Abstract] [Full Text] [Related]
8. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S; Sasaki M; Kobayashi T; Matsuda T Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
9. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)]. Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253 [No Abstract] [Full Text] [Related]
10. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs]. Delli Veneri F; Centrella G; Stefanelli R Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475 [No Abstract] [Full Text] [Related]
11. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis. Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105 [No Abstract] [Full Text] [Related]
12. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide]. Chioléro R Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521 [No Abstract] [Full Text] [Related]
13. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)]. Constans P; Parrot R; Coury C Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883 [No Abstract] [Full Text] [Related]
14. [Rifampicin in the treatment of lung and kidney tuberculosis]. Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064 [No Abstract] [Full Text] [Related]
15. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related]
16. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics]. Golyshevskaia VI; El'shanskaia MP Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666 [No Abstract] [Full Text] [Related]
17. [Drug therapy of tuberculosis in the child]. Freerksen E Monatsschr Kinderheilkd (1902); 1969 Aug; 117(8):513-8. PubMed ID: 4921462 [No Abstract] [Full Text] [Related]
18. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002). Negi SS; Gupta S; Lal S J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)]. Hétrick G; Muñoz I; Ras R Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795 [No Abstract] [Full Text] [Related]
20. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis]. Lesobre R; Frey N Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051 [No Abstract] [Full Text] [Related] [Next] [New Search]